Erythropoietin promoted the proliferation of hepatocellular carcinoma through hypoxia induced translocation of its specific receptor

Abstract Background Erythropoietin (EPO) is a hypoxia-inducible stimulator of erythropoiesis. Besides its traditional application in anemia therapy, it offers an effective treatment in the cancer patients, especially those who receive chemotherapy. Several reports indicated that it could promote the...

Full description

Bibliographic Details

Published in:	Cancer Cell International
Main Authors:	Shuo Miao, Su-Mei Wang, Xue Cheng, Yao-Feng Li, Qing-Song Zhang, Gang Li, Song-Qing He, Xiao-Ping Chen, Ping Wu
Format:	Article
Language:	English
Published:	BMC 2017-12-01
Subjects:	Erythropoietin Erythropoietin receptor Hepatocellular carcinoma Hypoxia Proliferation
Online Access:	http://link.springer.com/article/10.1186/s12935-017-0494-7